Journal profile · Medicine-Medicine (miscellaneous)
Gastro Hep Advances
ISSN 2772-5723 · Elsevier · United States
Gastro Hep Advances: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 3.3 (journal website); fully open access; APC about USD 2,200; median 111 days to acceptance (108 articles, last 24 months); 248 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Gastro Hep Advances is published by Elsevier and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Inflammatory Bowel Disease and Liver Disease and Transplantation, together about 26.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Gastro Hep Advances is a peer-reviewed journal published by the American Gastroenterological Association (AGA), joining Gastroenterology, Clinical Gastroenterology and Hepatology (CGH), Cellular and Molecular Gastroenterology and Hepatology (CMGH), and Techniques and Innovations in Gastrointestinal Endoscopy (TIGE). Gastro Hep Advances is a broad-scope, online-only, open access journal that publishes papers on basic, clinical, and translational gastroenterology and hepatology. The open access model enables authors with funding mandates to have a high-quality home for their research.In addition to full-length original research articles, the journal publishes comprehensive reviews as well as commentaries and editorials. A core objective is to publish papers cascaded from AGA's other journals that represent outstanding science and therefore qualify for publication in a journal supported by the AGA brand. Gastro Hep Advances also strongly encourages the submission of manuscripts not originally submitted to the other AGA journals. Gastro Hep Advances is less concerned with novelty and subjective perceptions of significance; its aim is to publish digestive disease research that is technically, ethically, and scientifically sound. Through its special sections, the journal also provides unique insights. Pearls from the Pros shares clinical pearls of knowledge developed through years of practice. Climate Change in Digestive Disease is a timely, relevant feature that delves into the impact of climate change on gastroenterology and hepatology. Gastro Hep Advances currently publishes monthly and shares updates on Facebook, X, Bluesky, and YouTube. The journal has been accepted into PubMed Central.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Editor-in-chief Anisa ShakerPublisher website
Editorial board by country: none in mainland China; most named United States 61, India 5, Spain 4, Japan 2, Canada 2 (77 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine10.9%
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology8.3%
- Liver Disease and TransplantationMedicine7.2%
- Colorectal Cancer Screening and DetectionMedicine6%
- Microscopic ColitisMedicine5.4%
- Pancreatitis Pathology and TreatmentMedicine4.3%
- Pancreatic and Hepatic Oncology ResearchMedicine4.1%
- Gastrointestinal motility and disordersMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.3Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher)
- 2.7Publisher website ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 0.72LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 103OpenAlex ·
- 2-year mean citedness
- 1.72OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 176LetPub ·
Articles by year OpenAlex count · 1,138 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 226 | 226 | 30 |
| 2025 | 248 | 248 | 380 |
| 2024 | 210 | 210 | 767 |
| 2023 | 209 | 209 | 866 |
| 2022 | 245 | 245 | 1,513 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
111 daysMedian, submission to acceptance · P25–P75 45 days – 167 days
- Acceptance to online
- median 6 days (108 articles)
- Submission to online
- median 116 days
- Sample
- 108 articles with submission and acceptance dates (518 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to first decision
- 9 daysPublisher website ·
- First decision after review
- 49 daysPublisher website ·
- Submission to acceptance
- 93 daysPublisher website ·
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,200 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 1,540 / USD 2,200 / USD 770 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 1,540
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 275 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 7,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required, 6
- Not considered
- Editorials
Article types accepted13, with length limits
- case reportCase Reports detail and analyze a particular case that may be of interest to Gastro Hep Advances' readership. Submissions must adhere to the following guideline…main text ≤ 1,000 words · abstract ≤ 100 words
- commentaryCommentaries express perspectives or provide information on current topics of interest in the field of gastroenterology and hepatology. They may be solicited or…main text ≤ 2,400 words
- correspondenceLetters to the Editor allow the opportunity to offer novel perspectives and opinions on full-length original research articles and research letters published in…main text ≤ 750 words
- editorialsThis article type is solicited by the board of editors and no unsolicited submissions will be considered.Length not stated
- narrative reviewNarrative Reviews discuss a particular topic of interest to the Gastro Hep Advances readership. Manuscript: New manuscripts can be uploaded as a single PDF with…main text ≤ 6,000 words · abstract ≤ 275 words
- narrative reviewsNarrative Reviews discuss a particular topic of interest to the Gastro Hep Advances readership.Length not stated
- original articleOriginal Articles are full-length reports of original research. Articles cover topics relevant to clinical, basic, and translational studies. Submissions must a…main text ≤ 7,000 words · abstract ≤ 275 words
- original articlesOriginal Articles are full-length reports of original research. Articles cover topics relevant to clinical, basic, and translational studies.Length not stated
- original researchARTICLE TYPESOriginal ArticlesOriginal Articles are full-length reports of original research. Articles cover topics relevant to clinical, basic, and translation…Length not stated
- research lettersResearch Letters are concise, meritorious scientific reports of original research.Length not stated
- reviewARTICLE TYPESOriginal ArticlesOriginal Articles are full-length reports of original research. Articles cover topics relevant to clinical, basic, and translation…Length not stated
- systematic reviewSystematic Reviews and Meta-analyses are manuscripts that feature an organized and detailed review of the scientific literature about a particular topic. For me…main text ≤ 6,000 words · abstract ≤ 275 words
- systematic reviews and meta-analysesSystematic Reviews and Meta-analyses are manuscripts that feature an organized and detailed review of the scientific literature about a particular topic.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints
- AI use Generative AI and Figures, images and artwork
Please read our policy on the use of generative AI and AI-assisted tools in figures, images and artwork, which can be found in Elsevier’s GenAI Policies for Journals. This policy states: AI tools may be used to support the creation of explanatory images (such as flow charts, conceptual diagrams, or schematic illustrations)AI tools may be used to create data visualizations (such as plots, charts, g…
Source ↗Publisher website ·- Authorship Authorship
Each author must have participated sufficiently in the work to take public responsibility for the content of the paper and must approve of the final version of the manuscript. Authorship should be based on substantive contributions to each of the following: conception and design of the studygeneration, collection, assembly, analysis and/or interpretation of datadrafting or revision of the manuscri…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Policy
Potential Conflicts of InterestThe following are examples of conflicts of interest (COI) that may occur with editors, authors (including invited authors), and reviewers. Interactions considered pertinent are from the start of the research activity in a specific program until such time that a submission is anticipated to be published or 1 year from submission date, whichever is longer.Editors: Edit…
Source ↗Publisher website ·- Data availability Data Sharing
Data citation: authors must cite underlying/relevant datasets in text and include data reference in reference list with specified elements and [dataset] identifier. Model summary
Gastro Hep Advances requires that clinical trial reports address the authors' intent to share deidentified individual participant data. To that end, authors must include a data sharing statement on the title page under the heading "Data Transparency Statement." The statement should include the following information: Whether deidentified individual participant data will be sharedWhich particular da…
Source ↗Publisher website ·- Publication ethics Ethical Standards
Gastro Hep Advances strongly discourages the submission of more than 1 article dealing with related aspects of the same study. In almost all cases, a single study is best reported in a single paper.The journal editors consider research/publication misconduct to be a serious breach of ethics and will take action as necessary to address such misconduct, which includes submission or publication of in…
Source ↗Publisher website ·- Open access Open Access Policies
Compliance with Funders' Open Access PoliciesGastro Hep Advances' publishing partner, Elsevier, has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with manuscript archiving requirements of various funding bodies (eg, the National Institutes of Health) as specified as conditions of researcher grant awards. For a full list of funding bodies …
Source ↗Publisher website ·- Peer review Peer Review
The Board of Editors evaluates manuscripts submitted to GHA and manages the peer review process. This journal operates a single anonymized review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editors-in-Chief make the final decision regarding acceptance or rejection of articles. The Editor's decisio…
Source ↗Publisher website ·- Plagiarism Plagiarism, Duplicate Submission/Publication Policy
DefinitionsPlagiarism is the unreferenced use of published and unpublished ideas. It may occur at any stage of planning, research, writing, or publication and applies to print and electronic versions.Duplicate submission/publication occurs when 2 or more papers, without full cross-reference, share the same hypothesis, data, discussion points, or conclusions.SanctionsShould plagiarism or duplicate …
Source ↗Publisher website ·- Preprints Preprint Server Policy
Preprint server policy: preprints allowed with stipulations; cannot be updated while under review or after acceptance; must be noted on title page with DOI; clinically oriented preprints discouraged; only from platforms allowing linking to published article (e.g., bioRxiv). Model summary
Gastro Hep Advances allows manuscript submissions to have been posted to a preprint server, with the following stipulations:The preprint cannot be updated while the manuscript is under review and cannot be updated if it is accepted for publication in the journal, even if the preprint server directs the author to do otherwise.If a manuscript is already submitted to an AGA journal and is under revie…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United States
- Language
- English
- ISSN
- 2772-5723
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Gastro Hep Advances
What CAS zone is Gastro Hep Advances in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Gastro Hep Advances?
The journal's website gives an impact factor of 3.3; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.7, h-index 22.
How long does peer review take at Gastro Hep Advances?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 45–167 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Gastro Hep Advances?
According to the journal's author guidelines: Abstract: ≤ 275 words; Keywords: ≥ 4; Manuscript length: ≤ 7,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Required, 6. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Gastro Hep Advances based?
Of the 77 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (61), India (5) and Spain (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Gastro Hep Advances?
According to LetPub and DOAJ records, Gastro Hep Advances is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Gastro Hep Advances open access, and what is the APC?
Gastro Hep Advances is a fully open-access journal. APC about USD 2,200.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .